Vertex Pharmaceuticals (VRTX)
(Delayed Data from NSDQ)
$445.21 USD
+4.57 (1.04%)
Updated May 17, 2024 04:00 PM ET
After-Market: $445.23 +0.02 (0.00%) 5:38 PM ET
3-Hold of 5 3
C Value B Growth B Momentum B VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/06/2024
Time: -- |
6/2024 | $4.13 | 0.18% |
Earnings Summary
For their last quarter, Vertex Pharmaceuticals (VRTX) reported earnings of $4.76 per share, beating the Zacks Consensus Estimate of $4.10 per share. This reflects a positive earnings surprise of 16.10%. Look out for VRTX's next earnings release expected on August 06, 2024. For the next earning release, we expect the company to report earnings of $4.13 per share, reflecting a year-over-year increase of 6.17%.
Earnings History
Price & Consensus
Zacks News for VRTX
Here's Why Vertex Pharmaceuticals (VRTX) is a Strong Growth Stock
VRTX: What are Zacks experts saying now?
Zacks Private Portfolio Services